Congratulations to the 15 researchers with Principal Investigator (PI) status at UHN who have made Clarivate’s 2026 list of Highly Cited Researchers—identifying the world’s most influential scientists in bibliometrics and analytics. Across 62 countries and regions, 7,090 Highly Cited Researcher designations were awarded to 6,802 individuals.

Citations serve as a widely accepted measure of influence, indicating how frequently a scientific article is referenced in research. The Clarivate Highly Cited Researcher title is a distinct honour for researchers whose publications, over the past decade, rank among the top 1% most-cited publications in their respective fields and publication years.

In addition to this recognition, four of UHN's PIs were awarded the prestigious 'Cross-Field' distinction, representing these researchers' influential work across multiple research fields.

“To be counted among the world’s most cited scientists is to see your ideas taken up, built upon, and put into practice. Our Highly Cited Researchers show us what bold, collaborative science can achieve, and the difference it makes for patients around the world,” says Dr. Brad Wouters, Executive Vice-President of Science and Research at UHN.

The UHN PIs and the categories in which they received their distinction are listed below. To read more, see the Clarivate press release. 

Dr. Cheryl Arrowsmith | Cross-Field
Senior Scientist, UHN’s Princess Margaret Cancer Centre
Research focus: Structural and chemical biology of epigenetic regulators related to cancer and drug discovery.

Dr. Gary Bader | Cross-Field
Affiliate Scientist, UHN’s Princess Margaret Cancer Centre and Ajmera Transplant Centre
Research focus: Computational biology approaches that combine molecular and clinical data to understand disease and identify potential therapeutic targets.

Dr. David Cherney | Clinical Medicine
Senior Scientist, UHN’s Organ Systems & Integrated Health Sciences Research Institute
Research focus: The physiological factors that contribute to renal disease in people with diabetes.

Dr. Slava Epelman | Immunology
Senior Scientist, UHN’s Peter Munk Cardiac Centre
Research focus: How immune cells contribute to cardiac tissue injury and repair.

Dr. Eddy Fan | Clinical Medicine
Senior Scientist, UHN’s Lung and Respiratory Diseases Research Institute
Research focus: Advanced life support for acute respiratory failure and patient outcomes following critical illness.

Dr. Anthony Lang | Neuroscience and Behaviour
Senior Scientist, UHN’s Krembil Brain Institute
Research focus: Parkinson disease and other movement disorders, including their causes, progression, diagnosis, and treatment.

Dr. Andres Lozano | Neuroscience and Behaviour
Senior Scientist, UHN’s Krembil Brain Institute
Research focus: Brain mapping, deep brain stimulation and focused ultrasound in patients, and experimental models of brain diseases.

Dr. Tak Mak | Cross-Field
Senior Scientist, UHN’s Princess Margaret Cancer Centre
Research focus: Cellular and molecular mechanisms underlying cancer and immune responses and pathways involved in tumour development.

Dr. Rodrigo Mansur | Psychiatry and Psychology
Clinician Investigator, UHN’s Krembil Brain Institute
Research focus: Combining clinical and neurobiological methods to study mood and metabolic disorders.

Dr. Ozgur Mete | Biology and Biochemistry
Clinician Investigator, UHN’s Princess Margaret Cancer Centre
Research focus: Biomarker discovery for endocrine and neuroendocrine tumours.

Dr. Amit Oza | Clinical Medicine
Senior Scientist, UHN’s Princess Margaret Cancer Centre
Research focus: Targeted therapies and clinical trials for gynecologic cancers.

Dr. Joshua Rosenblat | Psychiatry and Psychology
Clinician Investigator, UHN’s Krembil Brain Institute
Research focus: Treatment-resistant depression, with a focus on pharmacological treatments of mood disorders.

Dr. Matthieu Schapira | Pharmacology and Toxicology
Affiliate Scientist, UHN’s Princess Margaret Cancer Centre
Research focus: Computational approaches to identify new drug targets and study disease-related proteins.

Dr. Lillian Siu | Cross-Field
Senior Scientist, UHN's Princess Margaret Cancer Centre
Research focus: New anticancer drug development, particularly head and neck malignancies.

Dr. Arndt Vogel | Clinical Medicine
Senior Scientist, UHN's Organ Systems & Integrated Health Sciences Research Institute
Research focus: Studying liver cancer evolution, therapy options and strategies, and mechanisms of drug resistance.